BRAF and colorectal cancer: Although the BRAF mutation was independently associated with a worse prognosis, subanalysis of the MSI-H and MSS colorectal cancer subgroups established no difference in survival in BRAF mutant and BRAF wild-type MSI-H colorectal cancers.